Professor of Medicine Georgetown University School of Medicine and Director of Hepatology Georgetown University Hospital with a longstanding interest in DILI and hepatic safety in clinical trials

Dr. William Lee is a highly distinguished Professor in the Department of Internal Medicine at UT Southwestern Medical Center and is a pioneer and a father figure in the field of acute liver failure (ALF). He was the principal investigator of the seminal US Acute Liver Failure Study Group which over the course of nearly three decades has made numerous contributions to the fields of ALF and DILI.

Dr. Raúl J. Andrade is Professor of Medicine and Director of the Department of Medicine at the University of Malaga in Spain. Dr. Andrade is the Founder and Director of the Spanish Drug Induced Liver Injury (DILI) Registry and serves as Chair of various working groups to include EASL CPG on Drug Induced Liver Injury, and CIOMS working group on DILI. Dr. Andrade is an expert of the World Health Organization, the European Medicines Agency (EMA) and the Spanish Medicines Agency in the Evaluation of liver safety of drugs.

Fernando Bessone is a full Professor of Gastroenterology and Chief of the Department of Gastroenterology and Hepatology at the University of Rosario Medical School in Argentina. Dr. Bessone is a member of the Expert Committee on viral hepatitis from the Argentinian Association for the study of the Liver (SAHE) and is an authority of DILI, especially causative agents and consequence of DILI in Latin America. He is the past-president of the Argentinian Association for Study of Liver Diseases (SAHE) and Ex-Director of the Argentinian Journal of Hepatology.

Dr. Raúl Contreras Omaña is a Professor and Researcher at the School of Medicine, Autonomous University of the State of Hidalgo and holds Certification by the Mexican Council of Gastroenterology. Dr. Omaña serves as Chief Researcher, Center for Study and Research in Liver and Toxicological Diseases (CEIHET) Pachuca. He made important contributions to enhance our understanding of DILI in Mexico.

Dr. Paul "Skip" Hayashi serves as Associate Director, Drug Induced Liver Injury, Division of Hepatology and Nutrition Center for Drug Evaluation and Research, US Food and Drug Administration. He previously was a Professor of Medicine and Medical Director of Liver Transplantation at the University of North Carolina, Chapel Hill, USA. He is considered an authority in DILI, especially in causality attribution and mortality from DILI and its regulatory aspects.

Dr. Naga Chalasani is currently David W. Crabb Professor of Gastroenterology and Hepatology and Adjunct Professor of Anatomy, Cell Biology & Physiology and Director of Terance Kahn Liver Research Program at Indiana University School of Medicine, serving as PI on several U01 and R01 awards from the NIH. He is one of the global experts in DILI and is the lead author of the American College of Gastroenterology Practice Guideline on the Diagnosis and Management of DILI.

Dr. Raj Vuppalanchi is a Professor of Medicine and holds the position of Director of Hepatology at Indiana University School of Medicine. He is a significant contributor to the Drug-Induced Liver Injury Network (DILIN) and is the Primary Investigator for several Phase I -3 clinical trials. He has made numerous highly important contributions to the field, especially related to herbal-and dietary DILI and DILI outcomes.